Magnetic particle imaging lymphography (MPIL): a technique for lymph node mapping

Abstract

During metastasis, tumour cells drain to nearby lymph nodes, the first of which are named the sentinel lymph node(s) (SLN). SLN biopsy (SLNB) determines if metastasis has occurred. Traditionally, SLNB involves injecting a technetium-labeled tracer peritumorally, pre-operative imaging with SPECT to locate the SLN, and surgery guided by a gamma probe to remove them. Limitations include a short tracer half-life, which can make scheduling the SLNB difficult, and radiation exposure to patients and healthcare workers. Alternatively, magnetic localization, with superparamagnetic iron oxide nanoparticles (SPIONs) as the tracer and a magnetometer to detect SPIONs in the SLN during surgery, can be used; however, this lacks pre-operative imaging capability. Magnetic Particle Imaging (MPI) is an emerging imaging modality that directly detects SPIONs, holding potential for pre-operative imaging in magnetic SLNB. SPIONs for SLNB should have rapid drainage, high SLN accumulation, and high specificity to the SLN. For MPI Lymphography (MPIL), high particle sensitivity is also important. This study assesses the in vivo pharmacokinetics for SLN mapping with MPIL in a murine model, using five commercially available SPIONs of varying iron core sizes and surface coatings (VivoTrax, VivoTrax+, Synomag-D70, Synomag-D70 PEG and Synomag-D70 PEG-mannose). Our results show that the peak MPI signal measured for different SPIONs using relaxometry does not necessarily predict the MPI signal measured in vivo from images and that both the core size and the hydrodynamic size contribute to the performance of SPIONs as tracers for MPIL. VivoTrax+ had a higher peak signal measured by relaxometry (more ideal core size) but a lower MPI signal in vivo in the SLN (less accumulation in the SLN due to hydrodynamic size). Synomag-D70 had a 2.5 times higher peak signal compared to VivoTrax as measured by relaxometry, a 2–3 times higher signal in vivo in the SLN at early timepoints, and a 5–6 times higher signal in vivo at the latest timepoint. This suggests similar SLN accumulation at early timepoints and higher accumulation at the late timepoint. Synomag-D70 PEG and Synomag-D70 PEG-mannose had more rapid clearance from the injection site compared to plain Synomag. The MPI signal was detected in higher echelon nodes (HENs) for all Synomag particles, with Synomag-D70 PEG-mannose having the lowest HEN signal at 24 hours. Overall, the mannose targeted version of Synomag met more of the criteria for what is considered a good tracer for SLNB, with higher clearance, accumulation and specificity compared to the other SPIONs tested in this study.

Graphical abstract: Magnetic particle imaging lymphography (MPIL): a technique for lymph node mapping

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
22 Jul 2025
Accepted
29 Nov 2025
First published
20 Jan 2026
This article is Open Access
Creative Commons BY-NC license

Nanoscale, 2026, Advance Article

Magnetic particle imaging lymphography (MPIL): a technique for lymph node mapping

N. Fernando, O. C. Sehl, B. Fellows, C. Saayujya and P. J. Foster, Nanoscale, 2026, Advance Article , DOI: 10.1039/D5NR03104D

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements